{"filing":{"accession_number":"0001683168-26-004956","cik":"0001787740","ticker":"VBIO","company_name":"Valion Bio, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"valion_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1787740/000168316826004956/valion_8k.htm"},"events":[{"id":11733,"run_id":10314,"accession_number":"0001683168-26-004956","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The filing discloses Item 3.02 (Unregistered Sales of Equity Securities) with a cross-reference to Item 8.01 for substantive details. Item 3.02 is the dedicated disclosure item for dilutive equity issuances such as private placements and PIPEs. While the actual transaction details are incorporated by reference to Item 8.01 (not shown in this excerpt), the presence of Item 3.02 itself signals an unregistered equity sale, which is material to investors as it affects share dilution and capital structure.","company_name":"Valion Bio, Inc.","ticker":"VBIO","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8395,"accession_number":"0001683168-26-004956","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses Item 3.02 (Unregistered Sales of Equity Securities) with a cross-reference to Item 8.01 for substantive details. Item 3.02 is the dedicated disclosure item for dilutive equity issuances such as private placements and PIPEs. While the actual transaction details are incorporated by reference to Item 8.01 (not shown in this excerpt), the presence of Item 3.02 itself signals an unregistered equity sale, which is material to investors as it affects share dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T13:21:06.246925+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8395,"accession_number":"0001683168-26-004956","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The filing discloses Item 3.02 (Unregistered Sales of Equity Securities) with a cross-reference to Item 8.01 for substantive details. Item 3.02 is the dedicated disclosure item for dilutive equity issuances such as private placements and PIPEs. While the actual transaction details are incorporated by reference to Item 8.01 (not shown in this excerpt), the presence of Item 3.02 itself signals an unregistered equity sale, which is material to investors as it affects share dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T13:21:06.246925+00:00","company_name":"Valion Bio, Inc.","ticker":"VBIO","filing_date":"2026-06-18"}]}